Gonadal suppression alters axillary steroid secretions in men, but does that affect olfactory social signaling?

Background and objective: Luteinizing hormone-releasing hormone agonists (LHRHa) suppress gonadal hormone production and are commonly used to treat prostate cancer (PC) in men and conditions ranging from uterine fibroids to estrogen-sensitive cancers in women. They are also used to delay sexual...

Full description

Bibliographic Details
Main Authors: Syed Imran Ali Shah, Hannah C. P. Wilson, Paul D. Abel, Richard J. Wassersug, Vít Třebický, Jitka Třebická Fialová, Caroline Allen, Hans H. Adomat, Robert H. Bell, Emma S. Tomlinson Guns, S. Craig Roberts
Format: Article
Language:English
Published: IMR (Innovative Medical Research) Press Limited 2021-07-01
Series:Journal of Men's Health
Subjects:
Online Access:https://oss.jomh.org/jomh/article/20210630-328/pdf/JOMH2021022501.pdf